Dr. Deb Ristvedt on Innovation in MIGS and the OMNI Edge Surgical System скачать в хорошем качестве

Dr. Deb Ristvedt on Innovation in MIGS and the OMNI Edge Surgical System

"Nothing comes along without a vision—a vision to innovate, a vision to make things better—especially for patient care. It’s just amazing how we have seen minimally invasive glaucoma surgery transform how we are treating glaucoma." "When we have so many options in the angle, I look at what has happened behind the scenes all these years. Nothing has come overnight. When you look at Sight Sciences, they had a vision in 2010—a vision to create a device that was going to restore the natural outflow pathway." "In 2018, I had the pleasure and the privilege of being an early adopter. This has really transformed how I think about glaucoma and how I'm able to manage my patients from the early onset of glaucoma to late disease. I think that's really important when you think about innovation and where we are going, because nothing is stagnant, and we have to continue to push ourselves to boundaries." "That's exactly what the OMNI has done over time, with now the OMNI Edge, which has more microliters of viscoelastic to be able to dilate the Schlemm’s canal in a really safe and effective manner." Deb Ristvedt, DO from Vance Thompson Vision in Alexandria, Minnesota. _________ OMNI® Edge with TruSync™ technology delivers the ultimate experience in interventional glaucoma. It enables a comprehensive, implant-free MIGS procedure that reduces intraocular pressure by addressing three areas of resistance in the aqueous outflow system—the trabecular meshwork, Schlemm’s canal, and the collector channels. Adaptable to all stages of primary open-angle glaucoma, OMNI can be performed as a standalone procedure or combined with cataract surgery. The OMNI® Edge Surgical System is indicated to reduce intraocular pressure in adult patients with primary open-angle glaucoma. Please visit http://www.sightsciences.com/omniedge for the full instructions for use, warnings, precautions, and adverse event information. © 2025 Sight Sciences. Sight Sciences, the Sight Sciences logo, and OMNI are registered trademarks of Sight Sciences. 07/2025 OM-3540-US.v2